SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis SGLT2 Inhibitors Increase the Risk of Diabetic Ketoacidosis

SGLT2 inhibitors are commonly used in the treatment of type 2 diabetes, but might their use also contribute to the potential development of diabetic ketoacidosis?Journal of Clinical Endocrinology & Metabolism
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news